186 related articles for article (PubMed ID: 23405208)
1. CCAAT/enhancer binding protein β (C/EBPβ) isoforms as transcriptional regulators of the pro-invasive CDH3/P-cadherin gene in human breast cancer cells.
Albergaria A; Resende C; Nobre AR; Ribeiro AS; Sousa B; Machado JC; Seruca R; Paredes J; Schmitt F
PLoS One; 2013; 8(2):e55749. PubMed ID: 23405208
[TBL] [Abstract][Full Text] [Related]
2. ICI 182,780 induces P-cadherin overexpression in breast cancer cells through chromatin remodelling at the promoter level: a role for C/EBPbeta in CDH3 gene activation.
Albergaria A; Ribeiro AS; Pinho S; Milanezi F; Carneiro V; Sousa B; Sousa S; Oliveira C; Machado JC; Seruca R; Paredes J; Schmitt F
Hum Mol Genet; 2010 Jul; 19(13):2554-66. PubMed ID: 20385540
[TBL] [Abstract][Full Text] [Related]
3. MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer.
Johansson J; Berg T; Kurzejamska E; Pang MF; Tabor V; Jansson M; Roswall P; Pietras K; Sund M; Religa P; Fuxe J
Oncogene; 2013 Dec; 32(50):5614-24. PubMed ID: 23955085
[TBL] [Abstract][Full Text] [Related]
4. Expression of the CCAAT/enhancer-binding proteins C/EBPalpha, C/EBPbeta and C/EBPdelta in breast cancer: correlations with clinicopathologic parameters and cell-cycle regulatory proteins.
Milde-Langosch K; Löning T; Bamberger AM
Breast Cancer Res Treat; 2003 May; 79(2):175-85. PubMed ID: 12825852
[TBL] [Abstract][Full Text] [Related]
5. P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation.
Paredes J; Albergaria A; Oliveira JT; Jerónimo C; Milanezi F; Schmitt FC
Clin Cancer Res; 2005 Aug; 11(16):5869-77. PubMed ID: 16115928
[TBL] [Abstract][Full Text] [Related]
6. The CCAAT/enhancer-binding protein beta-2 isoform (CEBPβ-2) upregulates galectin-7 expression in human breast cancer cells.
Campion CG; Labrie M; Grosset AA; St-Pierre Y
PLoS One; 2014; 9(5):e95087. PubMed ID: 24789216
[TBL] [Abstract][Full Text] [Related]
7. Functional association of PR and CCAAT/enhancer-binding protein beta isoforms: promoter-dependent cooperation between PR-B and liver-enriched inhibitory protein, or liver-enriched activatory protein and PR-A in human endometrial stromal cells.
Christian M; Pohnke Y; Kempf R; Gellersen B; Brosens JJ
Mol Endocrinol; 2002 Jan; 16(1):141-54. PubMed ID: 11773445
[TBL] [Abstract][Full Text] [Related]
8. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta.
Zhou J; Gurates B; Yang S; Sebastian S; Bulun SE
Cancer Res; 2001 Mar; 61(5):2328-34. PubMed ID: 11280806
[TBL] [Abstract][Full Text] [Related]
9. CCAAT/enhancer-binding protein beta (nuclear factor for interleukin 6) transactivates the human MDR1 gene by interaction with an inverted CCAAT box in human cancer cells.
Chen KG; Sale S; Tan T; Ermoian RP; Sikic BI
Mol Pharmacol; 2004 Apr; 65(4):906-16. PubMed ID: 15044620
[TBL] [Abstract][Full Text] [Related]
10. Stat3 and CCAAT/enhancer binding protein beta (C/EBP-beta) regulate Jab1/CSN5 expression in mammary carcinoma cells.
Shackleford TJ; Zhang Q; Tian L; Vu TT; Korapati AL; Baumgartner AM; Le XF; Liao WS; Claret FX
Breast Cancer Res; 2011 Jun; 13(3):R65. PubMed ID: 21689417
[TBL] [Abstract][Full Text] [Related]
11. Complex regulation of the fibroblast growth factor-binding protein in MDA- MB-468 breast cancer cells by CCAAT/enhancer-binding protein beta.
Kagan BL; Henke RT; Cabal-Manzano R; Stoica GE; Nguyen Q; Wellstein A; Riegel AT
Cancer Res; 2003 Apr; 63(7):1696-705. PubMed ID: 12670924
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of elafin in normal and tumor-derived mammary epithelial cells is mediated by CCAAT/enhancer binding protein beta.
Yokota T; Bui T; Liu Y; Yi M; Hunt KK; Keyomarsi K
Cancer Res; 2007 Dec; 67(23):11272-83. PubMed ID: 18056453
[TBL] [Abstract][Full Text] [Related]
13. P53 regulates CCAAT/Enhancer binding protein β gene expression.
Hu B; Liu T; Wu Z; Phan SH
Gene; 2023 Oct; 884():147675. PubMed ID: 37541559
[TBL] [Abstract][Full Text] [Related]
14. CCAAT/Enhancer binding protein β controls androgen-deprivation-induced senescence in prostate cancer cells.
Barakat DJ; Zhang J; Barberi T; Denmeade SR; Friedman AD; Paz-Priel I
Oncogene; 2015 Nov; 34(48):5912-22. PubMed ID: 25772238
[TBL] [Abstract][Full Text] [Related]
15. HER2 silences tumor suppression in breast cancer cells by switching expression of C/EBPß isoforms.
Arnal-Estapé A; Tarragona M; Morales M; Guiu M; Nadal C; Massagué J; Gomis RR
Cancer Res; 2010 Dec; 70(23):9927-36. PubMed ID: 21098707
[TBL] [Abstract][Full Text] [Related]
16. CCAAT/enhancer binding proteins alpha and beta regulate the tumor necrosis factor receptor 1 gene promoter.
Bristol JA; Morrison TE; Kenney SC
Mol Immunol; 2009 Aug; 46(13):2706-13. PubMed ID: 19523687
[TBL] [Abstract][Full Text] [Related]
17. Expression and function of CCAAT/enhancer binding proteinbeta (C/EBPbeta) LAP and LIP isoforms in mouse mammary gland, tumors and cultured mammary epithelial cells.
Dearth LR; Hutt J; Sattler A; Gigliotti A; DeWille J
J Cell Biochem; 2001; 82(3):357-70. PubMed ID: 11500913
[TBL] [Abstract][Full Text] [Related]
18. C/EBP transcription factors in human squamous cell carcinoma: selective changes in expression of isoforms correlate with the neoplastic state.
Anand S; Ebner J; Warren CB; Raam MS; Piliang M; Billings SD; Maytin EV
PLoS One; 2014; 9(11):e112073. PubMed ID: 25402211
[TBL] [Abstract][Full Text] [Related]
19. C/EBPbeta interacts with the P-enolpyruvate carboxykinase adipocyte-specific enhancer.
Eubank DW; Williams SC; Beale EG
Biochem Biophys Res Commun; 2001 Jul; 285(3):811-9. PubMed ID: 11453665
[TBL] [Abstract][Full Text] [Related]
20. Transactivation of C-reactive protein by IL-6 requires synergistic interaction of CCAAT/enhancer binding protein beta (C/EBP beta) and Rel p50.
Agrawal A; Cha-Molstad H; Samols D; Kushner I
J Immunol; 2001 Feb; 166(4):2378-84. PubMed ID: 11160296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
